ID   U3117MG
AC   CVCL_IS00
SY   U3117-MG; U3117
DR   cancercelllines; CVCL_IS00
DR   GEO; GSM1857610
DR   GEO; GSM1857826
DR   GEO; GSM2368450
DR   GEO; GSM2368607
DR   Progenetix; CVCL_IS00
DR   Wikidata; Q54973731
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=27974212;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=27974212
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 16,18
ST   D5S818: 12,14
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IS01 ! U3118MG
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
RX   PubMed=26629530; DOI=10.1016/j.ebiom.2015.08.026; PMCID=PMC4634360;
RA   Xie, Yuan
RA   Bergstrom, Tobias
RA   Jiang, Yi-Wen
RA   Johansson, Patrik
RA   Marinescu, Voichita Dana
RA   Lindberg, Nanna
RA   Segerman, Anna
RA   Wicher, Grzegorz
RA   Niklasson, Mia
RA   Baskaran, Sathishkumar
RA   Sreedharan, Smitha
RA   Everlien, Isabelle
RA   Kastemar, Marianne
RA   Hermansson, Annika
RA   Elfineh, Lioudmila
RA   Libard, Sylwia
RA   Holland, Eric Charles
RA   Hesselager, Goran
RA   Alafuzoff, Irina
RA   Westermark, Bengt
RA   Nelander, Sven
RA   Forsberg-Nilsson, Karin
RA   Uhrbom, Lene
RT   "The Human Glioblastoma Cell Culture resource: validated cell models
RT   representing all molecular subtypes.";
RL   EBioMedicine 2:1351-1363(2015).
//
RX   PubMed=28122246; DOI=10.1016/j.celrep.2017.01.003;
RA   Jiang, Yi-Wen
RA   Marinescu, Voichita Dana
RA   Xie, Yuan
RA   Jarvius, Malin
RA   Maturi, Naga Prathyusha
RA   Haglund, Caroline
RA   Olofsson, Sara
RA   Lindberg, Nanna
RA   Olofsson, Tommie
RA   Leijonmarck, Caroline
RA   Hesselager, Goran
RA   Alafuzoff, Irina
RA   Fryknas, Marten
RA   Larsson, Rolf
RA   Nelander, Sven
RA   Uhrbom, Lene
RT   "Glioblastoma cell malignancy and drug sensitivity are affected by the
RT   cell of origin.";
RL   Cell Rep. 18:977-990(2017).
//
RX   PubMed=27974212; DOI=10.1016/j.celrep.2016.11.056;
RA   Segerman, Anna
RA   Niklasson, Mia
RA   Haglund, Caroline
RA   Bergstrom, Tobias
RA   Jarvius, Malin
RA   Xie, Yuan
RA   Westermark, Ann
RA   Sonmez, Demet
RA   Hermansson, Annika
RA   Kastemar, Marianne
RA   Naimaie-Ali, Zeinab
RA   Nyberg, Frida
RA   Berglund, Malin
RA   Sundstrom, Magnus
RA   Hesselager, Goran
RA   Uhrbom, Lene
RA   Gustafsson, Mats
RA   Larsson, Rolf
RA   Fryknas, Marten
RA   Segerman, Bo
RA   Westermark, Bengt
RT   "Clonal variation in drug and radiation response among
RT   glioma-initiating cells is linked to proneural-mesenchymal
RT   transition.";
RL   Cell Rep. 17:2994-3009(2016).
//
RX   PubMed=27689322; DOI=10.18632/oncotarget.12298; PMCID=PMC5341973;
RA   Schmidt, Linnea
RA   Baskaran, Sathishkumar
RA   Johansson, Patrik
RA   Padhan, Narendra
RA   Matuszewski, Damian J.
RA   Green, Lydia C.
RA   Elfineh, Lioudmila
RA   Wee, Shi-Mei
RA   Haggblad, Maria
RA   Martens, Ulf
RA   Westermark, Bengt
RA   Forsberg-Nilsson, Karin
RA   Uhrbom, Lene
RA   Claesson-Welsh, Lena
RA   Andang, Michael
RA   Sintorn, Ida-Maria
RA   Lundgren, Bo
RA   Lonnstedt, Ingrid
RA   Krona, Cecilia
RA   Nelander, Sven
RT   "Case-specific potentiation of glioblastoma drugs by pterostilbene.";
RL   Oncotarget 7:73200-73215(2016).
//